Healthcare · Pharmaceuticals & Biotechnology
QVM read Quality business Quality Strong, Valuation Fairly Valued, Momentum Neutral
Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.
Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.
PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.
Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.
Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.
Ranks #85 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.
| Filed | Person | Category | Type | Quantity | Value |
|---|---|---|---|---|---|
| 29 May 2025 | S Jeyakanth | Other | Sell | 0 | ₹0 |
| 1 Oct 2024 | NAGESWARAMMA PRIVATE TRUST | Promoter | Sell | 0 | ₹0 |
| 30 Sep 2024 | NAGESWARAMMA PRIVATE TRUST | Promoter | Sell | 0 | ₹0 |
| 21 Jun 2022 | RAMAA PRABHAKAR ARIKIREVULARA | Promoter | Buy | 0 | ₹0 |
| 21 Jun 2022 | Amulya Kamakshi Priya Arikirevula | Promoter | Buy | 0 | ₹0 |
| 20 Jun 2022 | S SAMBHUPRASAD | Promoter | Buy | 0 | ₹0 |
| 20 Jun 2022 | S SAMBHU PRASAD EXECUTOR TO THE ESTATE OF S RAMAYAMMA | Promoter | Sell | 0 | ₹0 |
| 15 Jun 2022 | S SAMBHU PRASAD EXECUTOR TO THE ESTATE OF S RAMAYAMMA | Promoter | Buy | 0 | ₹0 |
| 15 Jun 2022 | S RAMAYAMMA | Promoter | Sell | 0 | ₹0 |
| 17 May 2022 | PASUMARTHI SATHYANARAYANA MURTHI | Promoter group | Sell | 0 | ₹0 |
| Date | Client | Deal | Action | Quantity | Price | Exchange |
|---|---|---|---|---|---|---|
| 20 Aug 2026 | ENVISION INDIA FUND | Bulk | Sell | 213,000 | 523.5800 | NSE |
| 20 Aug 2026 | DSP MUTUAL FUND | Bulk | Sell | 500,000 | 500.0100 | BSE |
| 20 Aug 2026 | PARI WASHINGTON INDIA MASTER FUND, LTD. | Bulk | Buy | 583,481 | 500.0000 | BSE |
| 13 Jan 2025 | SUNDARAM MUTUAL FUND | Bulk | Sell | 213,500 | 700.0000 | NSE |
| 27 Sep 2024 | NAGESWARAMMA PRIVATE TRUST | Bulk | Sell | 340,275 | 745.2900 | BSE |
| 26 Sep 2024 | NAGESWARAMMA PRIVATE TRUST | Bulk | Sell | 832,725 | 760.0800 | NSE |
| 26 Sep 2024 | ICICI PRUDENTIAL MUTUAL FUND | Bulk | Buy | 650,000 | 760.0000 | NSE |
| 30 Jun 2023 | GRAVITON RESEARCH CAPITAL LLP | Bulk | Buy | 191,539 | 737.2100 | NSE |
| 30 Jun 2023 | GRAVITON RESEARCH CAPITAL LLP | Bulk | Sell | 191,539 | 737.8600 | NSE |
| 10 Jun 2020 | N.K.SECURITIES | Bulk | Buy | 371,237 | 384.9700 | NSE |
| Ex-date | Subject | Per share (₹) | Record date |
|---|---|---|---|
| — | Final Dividend - Rs. - 2.9000 | — | — |
Bonuses, splits, buybacks and other events. Dividends are listed separately above.
| Ex-date | Type | Subject |
|---|---|---|
| — | NAME_CHANGE | Name changed from Amrutanjan Ltd. to Amrutanjan Health Care Ltd. |
Quarterly results, AGMs, buybacks and other board-approved business.
| Date | Purpose | Results |
|---|---|---|
| 11 Aug 2026 | Financial Results | Yes |
| 8 May 2026 | Financial Results/Dividend | Yes |
| 3 Feb 2026 | Financial Results/Dividend | Yes |
| 10 Nov 2025 | Financial Results/Dividend | Yes |
| 12 Aug 2025 | Financial Results | Yes |
Exchange disclosures (NSE and BSE), most recent first.
| Date | Category | Announcement |
|---|---|---|
| 25 Sep 2026 | Insider Trading / SAST | Amrutanjan Health Care Ltd-$ - 590006 - Closure of Trading Window |
Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.
Data unavailable.
Data unavailable.
Board of directors and corporate information →
Data unavailable (no single-stock futures or options activity on record for this company).
The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.
The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.
The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.
No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.
